Laser Focus World is an industry bedrock—first published in 1965 and still going strong. We publish original articles about cutting-edge advances in lasers, optics, photonics, sensors, and quantum technologies, as well as test and measurement, and the shift currently underway to usher in the photonic integrated circuits, optical interconnects, and copackaged electronics and photonics to deliver the speed and efficiency essential for data centers of the future.

Our 80,000 qualified print subscribers—and 130,000 12-month engaged online audience—trust us to dive in and provide original journalism you won’t find elsewhere covering key emerging areas such as laser-driven inertial confinement fusion, lasers in space, integrated photonics, chipscale lasers, LiDAR, metasurfaces, high-energy laser weaponry, photonic crystals, and quantum computing/sensors/communications. We cover the innovations driving these markets.

Laser Focus World is part of Endeavor Business Media, a division of EndeavorB2B.

Laser Focus World Membership

Never miss any articles, videos, podcasts, or webinars by signing up for membership access to Laser Focus World online. You can manage your preferences all in one place—and provide our editorial team with your valued feedback.

Magazine Subscription

Can you subscribe to receive our print issue for free? Yes, you sure can!

Newsletter Subscription

Laser Focus World newsletter subscription is free to qualified professionals:

The Daily Beam

Showcases the newest content from Laser Focus World, including photonics- and optics-based applications, components, research, and trends. (Daily)

Product Watch

The latest in products within the photonics industry. (9x per year)

Bio & Life Sciences Product Watch

The latest in products within the biophotonics industry. (4x per year)

Laser Processing Product Watch

The latest in products within the laser processing industry. (3x per year)

Get Published!

If you’d like to write an article for us, reach out with a short pitch to Sally Cole Johnson: [email protected]. We love to hear from you.

Photonics Hot List

Laser Focus World produces a video newscast that gives a peek into what’s happening in the world of photonics.

Following the Photons: A Photonics Podcast

Following the Photons: A Photonics Podcast dives deep into the fascinating world of photonics. Our weekly episodes feature interviews and discussions with industry and research experts, providing valuable perspectives on the issues, technologies, and trends shaping the photonics community.

Editorial Advisory Board

  • Professor Andrea M. Armani, University of Southern California
  • Ruti Ben-Shlomi, Ph.D., LightSolver
  • James Butler, Ph.D., Hamamatsu
  • Natalie Fardian-Melamed, Ph.D., Columbia University
  • Justin Sigley, Ph.D., AmeriCOM
  • Professor Birgit Stiller, Max Planck Institute for the Science of Light, and Leibniz University of Hannover
  • Professor Stephen Sweeney, University of Glasgow
  • Mohan Wang, Ph.D., University of Oxford
  • Professor Xuchen Wang, Harbin Engineering University
  • Professor Stefan Witte, Delft University of Technology

Veradigm Adds Social Determinants of Health and Mortality Data to EHR Database to Allow Deeper Insights into the Patient Journey

Veradigm Network EHR (VNEHR) Data includes over 154M unique patients nationally, transforming research capabilities and advancing patient care

Veradigm® (OTCMKTS: MDRX), a leading provider of healthcare data and technology solutions, today announced the integration of two new datasets to expand the depth and breadth of Veradigm Network EHR (VNEHR) Data, one of the nation’s most comprehensive ambulatory electronic health record (EHR) databases. The database enrichment includes social determinants of health (SDoH) and mortality data, giving researchers new insights to tackle health disparities, enhance real-world evidence (RWE) studies, improve care, and offer strategic and operational benefits for life science companies.

“With our NLP-derived SDoH and mortality data, life sciences organizations gain a competitive advantage by moving beyond traditional clinical measures to explore the full spectrum of factors influencing patient health,” said Stuart Green, Vice President & General Manager of Life Sciences Business for Veradigm. “This innovation unlocks new research opportunities and can position organizations as leaders in advancing health equity and improving patient outcomes.”

Currently, 80% of critical patient information is locked within unstructured data, including clinical notes, leading to an incomplete view of a patient's health journey. However, with VNEHR Data, the combination of scale, diversity, and advanced natural language processing (NLP) technology provides research-ready, de-identified data optimized for life science, public health, and academic research. Now with a complete view, these stakeholders can gain deeper insights into therapeutic decisions, disease progression, and patient outcomes across various therapeutic areas.

The new NLP-derived SDoH data within VNEHR Data provides researchers with insights into socioeconomic, environmental and behavioral factors, including income levels, education, housing stability, and social support, areas that can be overlooked in traditional clinical data. By extracting nuanced SDoH information, Veradigm is enabling researchers to take a more holistic view of the patient and explore the intersection of clinical and social factors influencing health outcomes. This will help life science organizations enhance treatment insights, advance evidence generation, support market access strategies, and refine patient segmentation.

In addition, ambulatory EHR mortality data provides researchers with meaningful insights into patient populations and associated outcomes within outpatient care settings. This foundational dataset helps life science organizations enhance RWE generation by demonstrating long-term safety and efficacy and supporting post-market surveillance by identifying mortality trends associated with drug or device use. Additional benefits include accelerating drug development through improved identification of patient populations at risk, demonstrating value to payers and providers through added evidence to support reimbursement decisions, and enhancing precision medicine efforts by combining mortality data with genetic and biomarker information.

About Veradigm®

Veradigm is a healthcare technology company that drives value through its unique combination of platforms, data, expertise, connectivity, and scale. The Veradigm Network features a dynamic community of solutions and partners providing advanced insights, technology, and data-driven solutions for the healthcare provider, payer, and biopharma markets. For more information about how Veradigm is fulfilling its mission of Transforming Health, Insightfully, visit www.veradigm.com, or find Veradigm on LinkedIn, Facebook, Twitter, Instagram, and YouTube.

© 2025 Veradigm LLC and/or its affiliates. All rights reserved. Cited marks are the property of Veradigm LLC and/or its affiliates. All other product or company names are the property of their respective holders, all rights reserved.

Contacts

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.